ZENGİN, E. Et Al. 2019. Resistant bilateral chylous effusion as a late adverse effect of dasatinib treatment in chronic myeloid leukemia. European medical journal (EMJ), Hematology , no.7 , 93-97.

ZENGİN, E., SARPER, N., AYLAN GELEN, S., & TOPÇU, S., (2019). Resistant bilateral chylous effusion as a late adverse effect of dasatinib treatment in chronic myeloid leukemia. European medical journal (EMJ), Hematology , no.7, 93-97.

ZENGİN, EMİNE Et Al. "Resistant bilateral chylous effusion as a late adverse effect of dasatinib treatment in chronic myeloid leukemia," European medical journal (EMJ), Hematology , no.7, 93-97, 2019

ZENGİN, EMİNE Et Al. "Resistant bilateral chylous effusion as a late adverse effect of dasatinib treatment in chronic myeloid leukemia." European medical journal (EMJ), Hematology , no.7, pp.93-97, 2019

ZENGİN, E. Et Al. (2019) . "Resistant bilateral chylous effusion as a late adverse effect of dasatinib treatment in chronic myeloid leukemia." European medical journal (EMJ), Hematology , no.7, pp.93-97.

@article{article, author={EMİNE ZENGİN Et Al. }, title={Resistant bilateral chylous effusion as a late adverse effect of dasatinib treatment in chronic myeloid leukemia}, journal={European medical journal (EMJ), Hematology}, year=2019, pages={93-97} }